GleamWall
中文EN

KRMD KORU Medical Systems, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 704440 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY18.4%
TTM net income YoY77.8%
TTM EPS YoY92.9%
Revenue 3-yr CAGR17.3%
Net income 3-yr CAGR—

Margins

Gross margin63.6%
Operating margin-1.3%
Net margin-1.8%
FCF margin-0.8%
EBITDA margin0.4%

Returns

ROE-4.6%
ROA-2.9%
ROIC (approx.)-4.7%
Asset turnover1.66x

Leverage & solvency

Liabilities / assets32.6%
Debt / equity0.00x
Current ratio2.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.54x
Accruals ratio-4.5%
Payout ratio—
Capex / revenue1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$11.57M$12.05M$11.76M$10.90M$10.40M$10.19M$9.64M$8.84M
Cost of revenue$4.02M$4.20M$4.53M$4.08M$4.14M$3.72M$3.59M$3.28M
Gross profit$7.55M$7.85M$7.23M$6.82M$6.26M$6.48M$6.05M$5.56M
R&D expense$1.28M$1.07M$1.32M$1.14M$933,107$1.19M$1.11M$1.11M
SG&A expense$5.87M$5.94M$6.58M$6.04M$5.99M$5.38M$5.96M$5.83M
Operating income$187,118$626,991-$864,923-$547,104-$867,679-$312,655-$1.25M-$1.59M
Pretax income$236,103$258,249-$807,078-$482,172-$778,116-$189,511-$1.17M-$1.56M
Income tax$18,000$5,800—$4,684-$150$17,356——
Net income$218,103$252,449-$807,078-$486,856-$777,966-$206,867-$1.17M-$1.56M
EBITDA$397,141$837,022-$667,392-$367,930-$663,197-$103,168-$1.03M-$1.38M
EPS (basic)0.000.01-0.02—-0.020.00-0.03—
EPS (diluted)0.000.01-0.02—-0.020.00-0.03—
Weighted avg. shares (diluted)46.73M49.51M46.36M—46.24M46.19M45.98M—
Balance sheet
Cash & equivalents$7.36M$8.29M$8.77M$8.87M$8.46M$8.05M$8.74M$9.58M
Receivables$6.38M$5.03M$5.98M$5.97M$5.41M$4.93M$5.95M$5.72M
Inventory$4.69M$4.51M$4.48M$3.68M$4.41M$3.95M$3.28M$2.80M
Current assets$20.14M$19.51M$20.59M$19.99M$19.42M$17.58M$19.00M$19.13M
PP&E, net$4.00M$3.93M$4.34M$4.47M$4.24M$4.37M$4.53M$4.29M
Intangibles$1.68M$1.66M$711,211$684,841$681,621$698,974$716,326$730,279
Total assets$28.78M$27.96M$28.59M$28.20M$27.10M$25.52M$27.22M$27.22M
Current liabilities$6.79M$7.18M$8.85M$8.19M$7.83M$6.05M$7.80M$7.20M
Total liabilities$9.39M$9.91M$11.67M$11.15M$10.64M$8.99M$10.87M$10.40M
Shareholders' equity$19.40M$18.05M$16.92M$17.05M$16.46M$16.53M$16.35M$16.81M
Shares outstanding46.38M46.15M46.13M46.37M46.29M46.23M46.14M45.96M
Cash flow statement
Operating cash flow-$882,830$216,113$14,663$1.09M$65,456-$460,340-$237,467$939,615
Capital expenditure$268,219$107,907$46,163$407,782$52,483$28,814$443,438-$43,567
Free cash flow-$1.15M$108,206-$31,500$686,974$12,973-$489,154-$680,905$983,182
Investing cash flow-$533,704-$577,367-$89,885-$421,655-$52,483-$28,814-$446,838$50,738
Financing cash flow$493,030-$118,816-$29,216-$264,908$396,330-$191,964-$160,808-$215,716
Depreciation & amortization$210,023$210,031$197,531$179,174$204,482$209,487$217,357$211,454
Stock-based compensation$927,868$457,774$681,510$972,812$627,393$415,744$697,590$699,789

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.